Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, the top managed care news included the bipartisan deal to stabilize the Affordable Care Act's insurance markets; coverage from the Academy of Managed Care Pharmacy 2017 Nexus; a plan to reduce clinician burnout at the computer; and an FDA advisory panel has recommended approval for semaglutide, a once-weekly GLP-1 receptor agonist.
Read more about the stories in this episode:
Deal Reached to Keep Health Insurance Subsidies
The Academy of Managed Care Pharmacy (AMCP) Nexus 2017
Kite Pharma's CAR T-Cell Treatment Approved, Cheaper Than Tisagenlecleucel
AMA Seeks to Make Health Data Work Better for Doctors, Patients
ACO & Emerging Healthcare Delivery Coalition® Fall 2017
FDA Panel Gives Nod to Once-Weekly Semaglutide for Type 2 Diabetes
Evidence-Based Oncology | October 2017
Listen below or through one of these podcast services:
iTunes: http://apple.co/2eYWTss
TuneIn: http://bit.ly/2gv7iwj
Stitcher: http://bit.ly/2gCqtFg
Survival, PROs Favor Cemiplimab Plus Chemotherapy vs Chemotherapy Alone in Advanced NSCLC
December 4th 2023For patients with advanced non–small cell lung cancer (NSCLC), regardless of PD-L1 status, cemiplimab plus chemotherapy had favorable survival benefits and patient-reported outcomes over chemotherapy alone.
Read More
SABCS 2023 Sessions Touch on "Every Aspect of Breast Cancer"
December 4th 2023The 46th annual San Antonio Breast Cancer Symposium will take place December 5-9, with new and experienced attendees able to choose and learn from a schedule overflowing with the latest developments in breast cancer science and research.
Read More